このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

The Effects of Caffeine and Vitamin C on Maximum Strength and Strength Endurance in Adolescents With Mild Mental Fatigue

2026年7月23日 更新者:Yunliang Zhang

Objective To investigate the independent and combined effects of caffeine and vitamin C on maximal strength and strength endurance in female adolescents with mild mental fatigue.

Methods A randomised, double-blind, crossover experimental design was adopted. Forty female college students presenting mild mental fatigue were recruited as participants. Each participant completed five laboratory sessions in total. The first session determined their one-repetition maximum (1RM) for bench press and back squat. The remaining four experimental sessions involved four supplement interventions administered in random order: placebo control, vitamin C (VC) alone, caffeine (CAF) alone, and combined caffeine plus vitamin C (CAF+VC). A one-week washout interval was arranged between every two supplementation trials.

In each test session, participants completed a 45-min Stroop task to induce mental fatigue prior to exercise assessments. Measurements included the Visual Analogue Scale for Mental Fatigue (VAS-MF), 1RM bench press and squat performance, as well as the maximal number of repetitions at 65% 1RM for both movements. Immediately after the strength endurance test, perceived exertion and muscle pain were rated. Blood glucose and blood lactate concentrations were sampled before and after all exercise protocols.

Supplementation was administered 1 hour prior to testing: a standard caffeine dosage of 3.0 mg per kg body mass and a single 500 mg dose of vitamin C were provided for the corresponding intervention groups.

調査の概要

研究の種類

介入

入学 (推定)

40

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  1. Aged between 18and 19years (adolescent)
  2. Able to complete standardized 1RM maximal strength test and muscular endurance protocol for back squat and bench press
  3. Meet criteria for mild mental fatigue verified by validated scale (PVT + VAS Mental Fatigue ≥4/10 or Brief Fatigue Inventory) prior to experimental session
  4. Habitual daily caffeine intake ≤ 150 mg/day (low-to-moderate habitual consumption)
  5. Non-smoker; no regular alcohol consumption
  6. Consistent strength training status: No physical training for the past 3 months, or maintenance of a consistent daily activity routine throughout the study
  7. Able to attend all scheduled testing visits, comply with pre-test restrictions (diet, sleep, exercise, supplements)
  8. Participant provides written assent; parent/legal guardian provides written informed consent
  9. Able to understand and follow verbal and written study instructions

Exclusion Criteria:

  1. History of cardiovascular disease, arrhythmia, hypertension, asthma requiring regular medication
  2. Known hypersensitivity or adverse reaction to caffeine, vitamin C
  3. Chronic neurological disorders: epilepsy, migraine disorder, ADHD with stimulant medication
  4. Current psychiatric diagnosis (anxiety, depression) receiving psychotropic medication
  5. Musculoskeletal injury in the past 3 months limiting lower/upper body maximal strength testing
  6. Regular intake of ergogenic supplements (creatine, beta-alanine, energy drinks) within 4 weeks before screening
  7. Use of any stimulants, anti-fatigue drugs, corticosteroids within 30 days prior to enrollment
  8. Chronic gastrointestinal disease, kidney stone history (vitamin C related risk)
  9. Irregular sleep-wake cycle, diagnosed sleep disorder
  10. Females: current pregnancy; regular oral contraceptive use
  11. Participated in other human intervention trials within past 8 weeks
  12. Investigator judges any condition that compromises participant safety or interferes with outcome measurements

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:順次割り当て
  • マスキング:ダブル

武器と介入

参加者グループ / アーム
介入・治療
実験的:コントロール
A randomized, double-blind, crossover design was employed. Professional coaches assessed the subjects' bench press and back squat performances to examine the effects of caffeine combined with vitamin C on maximum strength (1RM) and strength endurance (repetitions to failure at 65% of 1RM) during bench press and back squat training. 65% of 1RM is a widely recognized load for strength endurance testing [28]. The formal experiment consisted of five test sessions: one for familiarization with the entire experimental procedure and a preliminary 1RM test to reconfirm the 1RM measured three weeks prior to the study. The remaining four sessions were conducted sequentially for the control group, vitamin C (VC), caffeine (CAF), and caffeine plus vitamin C (CAF+VC) groups. Each test was spaced 7 days apart to eliminate carryover effects [30]. All tests were scheduled between 12:00 PM and 4:00 PM to control for the effects of circadian rhythms [30].
実験的:caf
A randomized, double-blind, crossover design was employed. Professional coaches assessed the subjects' bench press and back squat performances to examine the effects of caffeine combined with vitamin C on maximum strength (1RM) and strength endurance (repetitions to failure at 65% of 1RM) during bench press and back squat training. 65% of 1RM is a widely recognized load for strength endurance testing [28]. The formal experiment consisted of five test sessions: one for familiarization with the entire experimental procedure and a preliminary 1RM test to reconfirm the 1RM measured three weeks prior to the study. The remaining four sessions were conducted sequentially for the control group, vitamin C (VC), caffeine (CAF), and caffeine plus vitamin C (CAF+VC) groups. Each test was spaced 7 days apart to eliminate carryover effects [30]. All tests were scheduled between 12:00 PM and 4:00 PM to control for the effects of circadian rhythms [30].
実験的:VC
A randomized, double-blind, crossover design was employed. Professional coaches assessed the subjects' bench press and back squat performances to examine the effects of caffeine combined with vitamin C on maximum strength (1RM) and strength endurance (repetitions to failure at 65% of 1RM) during bench press and back squat training. 65% of 1RM is a widely recognized load for strength endurance testing [28]. The formal experiment consisted of five test sessions: one for familiarization with the entire experimental procedure and a preliminary 1RM test to reconfirm the 1RM measured three weeks prior to the study. The remaining four sessions were conducted sequentially for the control group, vitamin C (VC), caffeine (CAF), and caffeine plus vitamin C (CAF+VC) groups. Each test was spaced 7 days apart to eliminate carryover effects [30]. All tests were scheduled between 12:00 PM and 4:00 PM to control for the effects of circadian rhythms [30].
実験的:caf+VC
A randomized, double-blind, crossover design was employed. Professional coaches assessed the subjects' bench press and back squat performances to examine the effects of caffeine combined with vitamin C on maximum strength (1RM) and strength endurance (repetitions to failure at 65% of 1RM) during bench press and back squat training. 65% of 1RM is a widely recognized load for strength endurance testing [28]. The formal experiment consisted of five test sessions: one for familiarization with the entire experimental procedure and a preliminary 1RM test to reconfirm the 1RM measured three weeks prior to the study. The remaining four sessions were conducted sequentially for the control group, vitamin C (VC), caffeine (CAF), and caffeine plus vitamin C (CAF+VC) groups. Each test was spaced 7 days apart to eliminate carryover effects [30]. All tests were scheduled between 12:00 PM and 4:00 PM to control for the effects of circadian rhythms [30].

この研究は何を測定していますか?

主要な結果の測定

結果測定
時間枠
1RM Squats and Bench Presses;Number of repetitions for 65% 1RM squats and bench presses
時間枠:5 week
5 week

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年7月25日

一次修了 (推定)

2026年9月20日

研究の完了 (推定)

2026年9月22日

試験登録日

最初に提出

2026年7月17日

QC基準を満たした最初の提出物

2026年7月21日

最初の投稿 (実際)

2026年7月24日

学習記録の更新

投稿された最後の更新 (実際)

2026年7月27日

QC基準を満たした最後の更新が送信されました

2026年7月23日

最終確認日

2026年7月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

http://www.medresman.org.cn/login.aspx

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する